Replies to post #126914 on Biotech Values

[jbog]

however how many have the technology to obtain approval for multiple complex molecules?

All of them.

Clearly, Amphastar's model of creating, manufacturing and obtaining the filing alone is more profitable than Momenta's wait for a partner method. Hopefully some day Momenta, while skipping the mfg. process will do the same.